Contact Us
Whether you're a patient, clinician, researcher, or partner, we’d be happy to hear from you. LiquidMammo™ is currently in validation, and early access is offered through select practices.
LiquidMammo is being developed as a CLIA Laboratory Developed Test (LDT). It is not yet FDA‑cleared or FDA‑approved.
Who are you contacting us as?
Patients
Join the early‑access list, receive updates, or request supplemental screening information.
Email: support@liquidmammo.com
Clinicians
Learn about enrollment, workflow integration, sample kits, and validation collaboration.
Email: clinicians@liquidmammo.com
Research & Partnerships
For research collaborations, biobank access inquiries, or strategic partnerships.
Email: partnerships@liquidmammo.com
Send us a message
This form is intended for non‑confidential communication. Please do not include personal health information (PHI). If your inquiry requires the exchange of sensitive or clinical details, our team will follow up through a secure, HIPAA‑aligned channel.
Locations
Washington, DC
MultiOmics Inc.
Washington, DC 20001
(Headquarters)
Cambridge, MA
LabCentral – MIT Innovation Ecosystem
Cambridge, MA 02142
(R&D & Laboratory)